Letermovir Effectively Prevents Cytomegalovirus Infection in Patients with Aplastic Anemia After Hematopoietic Stem Cell Transplantation: A Real-World Retrospective Cohort Study
ConclusionsLetermovir effectively prevents CMV infection in allo-HSCT recipients with AA and demonstrates a high safety profile.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Anemia | Aplastic Anemia | Cytomegalovirus | Infectious Diseases | Stem Cell Therapy | Stem Cells | Study | Transplants